Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
6.90
+0.67 (10.75%)
At close: Mar 12, 2026, 4:00 PM EDT
6.78
-0.12 (-1.74%)
After-hours: Mar 12, 2026, 4:19 PM EDT

Atara Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
5078553151,4451,637
Market Cap Growth
17.61%42.86%-82.65%-78.22%-11.72%74.92%
Enterprise Value
48.8165.448.55129.891,0991,149
Last Close Price
6.9013.3112.8282.00394.00490.75
PE Ratio
3.51-1.17-0.20-1.46-4.34-4.73
PS Ratio
0.300.606.374.9571.03-
PB Ratio
--0.80-0.552.485.173.54
P/TBV Ratio
-2.23-1.02-0.552.645.283.14
P/FCF Ratio
--1.13-0.28-1.15-6.25-8.83
P/OCF Ratio
--1.13-0.28-1.16-6.55-9.05
EV/Sales Ratio
0.320.515.662.0454.04-
EV/EBITDA Ratio
1.09-0.83-0.18-0.47-3.32-3.82
EV/EBIT Ratio
1.14-0.78-0.18-0.46-3.23-3.72
EV/FCF Ratio
--0.95-0.25-0.47-4.76-6.20
Debt / Equity Ratio
-0.41-0.31-0.460.460.090.03
Debt / EBITDA Ratio
0.51-0.38-0.17-0.21-0.08-0.04
Debt / FCF Ratio
-0.21-0.43-0.23-0.21-0.11-0.07
Net Debt / Equity Ratio
-0.040.130.06-1.46-1.24-1.05
Net Debt / EBITDA Ratio
0.040.160.020.671.041.62
Net Debt / FCF Ratio
-0.020.180.030.671.502.63
Asset Turnover
0.470.940.030.150.040
Inventory Turnover
5.242.061.570--
Quick Ratio
0.870.330.603.593.526.05
Current Ratio
1.020.480.723.743.646.31
Return on Equity (ROE)
-34.95%86.92%-2014.86%-112.39%-91.69%-81.43%
Return on Assets (ROA)
37.64%-60.76%-101.87%-66.43%-64.48%-66.39%
Return on Invested Capital (ROIC)
85.39%-129.47%-333.98%-448.24%-799.67%-637.94%
Return on Capital Employed (ROCE)
-392.37%7592.17%-172.08%-85.02%-78.49%-76.18%
Earnings Yield
51.35%-85.73%-508.50%-68.29%-23.03%-21.14%
FCF Yield
-153.18%-88.43%-355.77%-87.28%-16.00%-11.32%
Buyback Yield / Dilution
-15.96%-77.17%-5.44%-7.37%-7.21%-26.16%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q